|
| |
Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms
|
Published: Jan 2012 | Pages: 76 | Pub ID: MM1326972010 |
|
|
|


|
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GBI Research Report Guidance
3 Veterinary Vaccines Market to 2017 - Market Overview
3.1 Revenue Forecasts
3.2 Drivers
3.2.1 Livestock Owners Developing Increased Disease Awareness for Farm Animals
3.3 Barriers
3.3.1 Mutant Strains of Virus Pose a Challenge in Vaccine Manufacturing
3.3.2 Decrease in Cattle Population is Reducing the Demand for Vaccines
4 Veterinary Vaccines Market to 2017 - Geographical Landscape
4.1 The US
4.1.1 Revenue Forecast
4.2 Europe
4.2.1 Revenue Forecast
4.3 Japan
4.3.1 Revenue Forecast
5 Veterinary Vaccines Market to 2017 - Bovine Vaccines Market
5.1 The US
5.1.1 Revenue Forecasts
5.1.2 Annual Cost of Vaccination
5.1.3 Target Population
5.2 Europe
5.2.1 Revenue Forecasts
5.2.2 Annual Cost of Vaccination
5.2.3 Target Population
5.3 Japan
5.3.1 Revenue Forecasts
5.3.2 Annual Cost of Vaccination
5.3.3 Target Population
6 Veterinary Vaccines Market to 2017 - Ovine Vaccines Market
6.1 The US (Sheep Vaccines Market)
6.1.1 Revenue Forecasts
6.1.2 Annual Cost of Vaccination
6.1.3 Target Population
6.2 Europe (Sheep Vaccine Market)
6.2.1 Revenue Forecasts
6.2.2 Annual Cost of Vaccination
6.2.3 Target Population
6.3 Japan (Sheep Vaccines Market)
6.3.1 Revenue Forecasts
6.3.2 Annual Cost of Vaccination
6.3.3 Target Population
6.4 The US (Goat Vaccines Market)
6.4.1 Revenue Forecasts
6.4.2 Annual Cost of Vaccination
6.4.3 Target Population
6.5 Europe (Goat Vaccines Market)
6.5.1 Revenue Forecasts
6.5.2 Annual Cost of Vaccination
6.5.3 Target Population
6.6 Japan (Goat Vaccines Market)
6.6.1 Revenue Forecasts
6.6.2 Annual Cost of Vaccination
6.6.3 Target Population
7 Veterinary Vaccines Market to 2017 - Porcine Vaccines Market
7.1 The US
7.1.1 Revenue Forecasts
7.1.2 Annual Cost of Vaccination
7.1.3 Target Population
7.2 Europe
7.2.1 Revenue Forecasts
7.2.2 Annual Cost of Vaccination
7.2.3 Target Population
7.3 Japan
7.3.1 Revenue Forecasts
7.3.2 Annual Cost of Vaccination
7.3.3 Target Population
8 Veterinary Vaccines Market to 2017 - Equine Vaccines Market
8.1 The US
8.1.1 Revenue Forecasts
8.1.2 Annual Cost of Vaccination
8.1.3 Target Population
8.2 Europe
8.2.1 Revenue Forecasts
8.2.2 Annual Cost of Vaccination
8.2.3 Target Population
8.3 Japan
8.3.1 Revenue Forecasts
8.3.2 Annual Cost of Vaccination
8.3.3 Target Population
9 Veterinary Vaccines Market to 2017 - Competitive Landscape
9.1 Company Profiles
9.1.1 Bayer HealthCare
9.1.2 Pfizer
9.1.3 Merck Inc.
9.1.4 Novartis
10 Veterinary Vaccines Market to 2017 - Product Profiles
10.1 Bovine Vaccines
10.1.1 Alpha-7
10.1.2 Vira Shield 6 + VL5
10.1.3 Salmonella Newport Bacterial Extract SRP
10.1.4 Imrab Large Animal
10.1.5 Anthrax Spore Vaccine
10.1.6 J-5 E. Coli Bacterin
10.2 Ovine Vaccines
10.2.1 Ultrabac 7
10.2.2 Ultrabac CD
10.2.3 Clostri Shield 7
10.3 Porcine Vaccines
10.3.1 Parvo Shield L5E
10.3.2 Porcine Pili Shield+C
10.3.3 LitterGuard LT-C
10.3.4 Farrowsure Gold B
10.4 Equine Vaccines
10.4.1 Recombitek Equine West Nile Virus Vaccine
10.4.2 Fluvac Innovator 6
10.4.3 Prestige V + VEE
10.4.4 Potomavac
10.4.5 Imrab 3
11 Veterinary Vaccines Market to 2017 - Mergers & Acquisitions
11.1 Phibro Animal Health Completed Acquisition of Abic Animal Health in February 2009
11.2 Ceva Acquired Vetech Laboratories in October 2011
11.3 Ceva Acquired CentaurVA Animal Health in October 2011
11.4 Harbin Pharma Acquired Pfizer’s Swine Vaccine Business in June 2010
11.5 Boehringer Ingelheim Animal Health Acquires a Significant Portion of the Fort Dodge Animal Health Business from Pfizer in October 2009
11.6 Pfizer Acquired Microtek International in May 2010
11.7 Virbac Acquired Certain Veterinary Products from Pfizer in February 2010
12 Veterinary Vaccines Market to 2017 - Licensing Agreements
12.1 Heska Corporation Amends Bovine Vaccine Agreement with AgriLabs
12.2 Pfizer Animal Health Inks Global Licensing Deal with Epitopix
12.3 GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD Vaccine
12.4 Vical Enters into Agreement with Japanese Partner for Veterinary Pandemic Influenza Vaccine
13 Veterinary Vaccines Market to 2017 - Recent Activities
13.1 Intervet’s Equine West Nile Vaccine Approved by USDA (United States Department of Agriculture)
13.2 Defra Launched Bovine Tuberculosis Vaccine
13.3 Boehringer Ingelheim Vetmedica Receives Approval for Express FP and Express Vaccines from the USDA
14 Veterinary Vaccines Market to 2017 - Appendix
14.1 Market Definitions
14.2 Abbreviations
14.3 Research Methodology
14.3.1 Coverage
14.3.2 Secondary Research
14.3.3 Primary Research
14.4 Therapeutic Landscape
14.4.1 Market Size by Geography
14.5 Geographical Landscape
14.6 Competitive Landscape
14.6.1 Expert Panel Validation
14.7 Contact Us
14.8 Disclaimer
14.9 Sources |
|
| By: GBI Research |
|
|
| |
|
|
|